tiprankstipranks
180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market

180 Life Sciences (ATNF) Stock Price & Analysis

241 Followers

ATNF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.31 - $21.28
Previous Close$2.14
Volume133.54K
Average Volume (3M)664.71K
Market Cap
$2.02M
Enterprise Value$1.09M
Total Cash (Recent Filing)$1.98M
Total Debt (Recent Filing)$1.05M
Price to Earnings (P/E)
Beta0.82
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-41.87
Shares Outstanding941,590
10 Day Avg. Volume109,718
30 Day Avg. Volume664,712
Standard Deviation0.96
R-Squared0.03
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.79
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ATNF FAQ

What was 180 Life Sciences’s price range in the past 12 months?
180 Life Sciences lowest stock price was $1.31 and its highest was $21.28 in the past 12 months.
    What is 180 Life Sciences’s market cap?
    Currently, no data Available
    When is 180 Life Sciences’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were 180 Life Sciences’s earnings last quarter?
    Currently, no data Available
    Is 180 Life Sciences overvalued?
    According to Wall Street analysts 180 Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does 180 Life Sciences pay dividends?
      180 Life Sciences does not currently pay dividends.
      What is 180 Life Sciences’s EPS estimate?
      180 Life Sciences’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does 180 Life Sciences have?
      180 Life Sciences has 941,590 shares outstanding.
        What happened to 180 Life Sciences’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of 180 Life Sciences?
        Currently, no hedge funds are holding shares in ATNF
        ---

        180 Life Sciences Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -89.42%
        12-Months-Change

        Fundamentals

        Return on Equity
        -525.19%
        Trailing 12-Months
        Asset Growth
        -76.94%
        Trailing 12-Months

        Company Description

        180 Life Sciences

        KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in Newark, DE.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Agenus
        Aldeyra Therapeutics
        Amarin
        Clearside Biomedical
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis